Doctor profile · Federal record
Dr. DANIA WILSON, NP
Adult Health Nurse Practitioner (CMS: NURSE PRACTITIONER) · NEW LONDON, CT
- NPI 1164856035
- Accepts Medicare
- 14 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
194 HOWARD ST
NEW LONDON, CT 063205544
(860) 444-4737
fax (860) 865-2375 - Additional location
-
45 Wells St Ste 104
Westerly, RI 028912927
Credentials & registration
- NPI registered
- August 2013 — 13 yrs on file
- Profile last updated
- April 27, 2020
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 363LA2200X — NUCC code
- State license (1)
- Rhode Island #APRN01341
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1164856035. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
474
Distinct HCPCS
7
Medicare allowed
$29,809
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 141 | 111 | $112 | |
83036 |
Hemoglobin a1c level | 137 | 104 | $9 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 104 | 72 | $30 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 34 | 34 | $80 | |
95250 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 23 | 21 | $150 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 21 | 21 | $148 | |
99211 |
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | 13 | $21 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 91. This provider delivers 5.2× the peer median.Open Payments
Industry payments received
All-time total
$279
Transactions
2
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbott Laboratories | 1 | $155.03 | |
| Amgen Inc. | 1 | $124.15 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
810
Patients
327
Total drug cost
$726,231
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 114 | 46 | $91,352 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 85 | 31 | $1,648 |
| Trulicity (Dulaglutide) | Brand | 83 | 28 | $140,151 |
| Nano 2nd Gen Pen Needle (Pen Needle, Diabetic) | Brand | 76 | 41 | $9,985 |
| Ozempic (Semaglutide) | Brand | 74 | 35 | $141,367 |
| Metformin Hcl | Generic | 54 | 27 | $924 |
| Humalog Kwikpen U-100 (Insulin Lispro) | Brand | 52 | 27 | $53,991 |
| Tresiba Flextouch U-100 (Insulin Degludec) | Brand | 50 | 24 | $51,918 |
| Jardiance (Empagliflozin) | Brand | 45 | 20 | $51,423 |
| Mounjaro (Tirzepatide) | Brand | 41 | 15 | $61,482 |